Periodically repeated rituximab administrations in children with refractory nephrotic syndrome: 2-year multicenter observational study

被引：0

作者：

Toshiyuki Takahashi

Takayuki Okamoto

Yasuyuki Sato

Takeshi Yamazaki

Asako Hayashi

Hayato Aoyagi

Michihiko Ueno

Norio Kobayashi

Kimiaki Uetake

Masanori Nakanishi

Tadashi Ariga

机构：

[1] Hokkaido University Graduate School of Medicine,Department of Pediatrics

[2] Obihiro Kyokai Hospital,Department of Pediatrics

[3] Nikko Memorial Hospital,Department of Pediatrics

[4] Oji General Hospital,Department of Pediatrics

[5] Obihiro Kosei Hospital,Department of Pediatrics

[6] Kushiro Red Cross Hospital,Department of Pediatrics

来源：

Pediatric Nephrology | 2019年 / 34卷

关键词：

Nephrotic syndrome; Children; Rituximab; Repeated administration; Mizoribine; Calcineurin inhibitor;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：87 / 96

页数：9

共 299 条

[31] Montini G(2007)Safety and efficacy of additional courses of rituximab in patients with active rheumatoid arthritis: an open-label extension analysis Arthritis Rheum 56 3896-3908
[32] Murtas C(2008)Rituximab treatment of idiopathic membranous nephropathy Kidney Int 73 117-125
[33] Wang X(2008)Variability in the biological response to anti-CD20 B cell depletion in systemic lupus erythaematosus Ann Rheum Dis 67 1724-1731
[34] Muruve D(2013)Does rituximab induce hypogammaglobulinemia in patients with pediatric idiopathic nephrotic syndrome? Pediatr Nephrol 28 447-451
[35] Vaglio A(undefined)undefined undefined undefined undefined-undefined
[36] Martorana D(undefined)undefined undefined undefined undefined-undefined
[37] Pani A(undefined)undefined undefined undefined undefined-undefined
[38] Scolari F(undefined)undefined undefined undefined undefined-undefined
[39] Reiser J(undefined)undefined undefined undefined undefined-undefined
[40] Ghiggeri GM(undefined)undefined undefined undefined undefined-undefined